Guidance for clinical investigators, institutional review boards, and sponsors : process for handling referrals to FDA under 21 CFR 50.54 : additional safeguards for children in clinical investigations.

Bibliographic Details
Corporate Author:	United States. Food and Drug Administration
Format:	Government Document eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, [2006]
Subjects:	Medical research personnel > Government policy > United States. Clinical trials > Government policy > United States. Pediatrics > Research > Government policy > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS112485

Description
Item Description:	Title from PDF title page (viewed on May 12, 2009). "December 2006". Electronic resource.
Physical Description:	i, 9 pages : digital, PDF file.
Format:	Mode of access: Internet at the FDA CBER web site. Address as of 5/12/09: http://www.fda.gov/cber/gdlns/childclininv.pdf ; current access is available via PURL.